The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry
Official Title: PROspective Evaluation of GErmline Mutations, Cancer Outcome and Tissue Biomarkers: A Registry for Patients With Triple Negative Breast Cancer and Germline Mutations
Study ID: NCT02302742
Brief Summary: PROGECT is a registry for patients with Triple Negative breast cancer (TNBC) or patients who have an identified germline mutations (such as a mutation on the BRCA1 or BRCA2 genes).
Detailed Description: This study is being done to collect cancer-related information from patients with triple negative breast cancer and patients with hereditary genetic mutations. This information will help us better understand the link between genetic changes and cancer outcome in patients with triple negative breast cancer.
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: Yes
Hays Medical Center Dreiling-Schmidt Cancer Institute, Hays, Kansas, United States
KCCC West, Kansas City, Kansas, United States
Menorah Medical Center, Overland Park, Kansas, United States
KCCC Overland Park, Overland Park, Kansas, United States
Overland Park Regional Medical Center, Overland Park, Kansas, United States
Salina Regional Health Center - Tammy Walker Cancer Center, Salina, Kansas, United States
The University of Kansas Cancer Center, Westwood, Kansas, United States
Centerpoint Regional Medical Center, Independence, Missouri, United States
Truman Medical Center, Kansas City, Missouri, United States
KCCC South, Kansas City, Missouri, United States
Research Medical Center, Kansas City, Missouri, United States
KCCC - North, Kansas City, Missouri, United States
KCCC Lee's Summit, Lee's Summit, Missouri, United States
Name: Priyanka Sharma, MD
Affiliation: The University of Kansas Medical Center
Role: PRINCIPAL_INVESTIGATOR